Pii’s Robotic Aseptic Fill-Finish
Pii’s Robotic Aseptic Fill-Finish line provides reliable and flexible processing, minimizes manual interventions, and reduces product losses, common at the beginning and end of batch manufacturing. The Robotic Aseptic Fill-Finish line compliments Pii’s larger volume production lines by offering clinical fill-finish manufacturing of cartridges, vials and syringes. With Batch Sizes from 1L – 1000L, Pii is your preferred Aseptic Fill-Finish CDMO. Learn More
Pii’s Large Scale Aseptic Fill-Finish
Pii’s Bosch Aseptic Fill-Finish line is perfect for handling large commercialization batches, filling up to 150-200 vials per minute. The Bosch accommodates both Ready to Use (RTU) and Ready to Sterilize (RTS) vials 2mL – 100mL.Pii is your preferred Aseptic Fill-Finish CDMO. Learn More
Pii's Aseptic Vial Fill-Finish
Pii’s M and O Perry Aseptic Fill-Finish line offers clinical and commercial fill-finish manufacturing of vials filling up to 40 vials per minute. This line supports batch sizes from (1L – 500L) and the ability to fill a vial size range from 3mL – 100mL. Pii is your preferred Aseptic Fill-Finish CDMO. Learn More
Pii’s Aseptic Pre-Filled Syringe Fill-Finish
Pii’s Groninger Syringe Fill-Finish line supports a range of injectables from clinical to commercial batch sizes up to 50,000 syringes per day with pre-filled syringe sizes ranging from 1mL – 10mL. Pii is your preferred Aseptic Fill-Finish CDMO. Learn More
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.